Overview Multiple Doses Escalation Study of SHR0302 in Rheumatoid Arthritis (RA) Patients Status: Unknown status Trial end date: 1969-12-31 Target enrollment: Participant gender: Summary Condition: Rheumatoid Arthritis Intervention: Drug: SHR0302; Drug: SHR0302 placebo comparator Phase: Phase 1 Study Type: Interventional Study Design: Treatment, Parallel Assignment, Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Randomized Phase: Phase 1 Details Lead Sponsor: Jiangsu HengRui Medicine Co., Ltd.